Assessment of underlying mechanisms indicated that circulating IGF-I impacts on the activity of the HPA axis, probably in part by regulating FKBP5 expression, which is also regulated by glucocorticoids35, and in this way regulates anxiety. The gene discussed is FKBP5; the disease is Anxiety.